Artificial intelligence-based pathology for gastrointestinal and hepatobiliary cancers

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Julien Calderaro - , Université Paris-Est Créteil, Hôpital Henri Mondor (Author)
  • Jakob Nikolas Kather - , German Cancer Research Center (DKFZ), RWTH Aachen University (Author)

Abstract

Artificial intelligence (AI) can extract complex information from visual data. Histopathology images of gastrointestinal (GI) and liver cancer contain a very high amount of information which human observers can only partially make sense of. Complementing human observers, AI allows an in-depth analysis of digitised histological slides of GI and liver cancer and offers a wide range of clinically relevant applications. First, AI can automatically detect tumour tissue, easing the exponentially increasing workload on pathologists. In addition, and possibly exceeding pathologist's capacities, AI can capture prognostically relevant tissue features and thus predict clinical outcome across GI and liver cancer types. Finally, AI has demonstrated its capacity to infer molecular and genetic alterations of cancer tissues from histological digital slides. These are likely only the first of many AI applications that will have important clinical implications. Thus, pathologists and clinicians alike should be aware of the principles of AI-based pathology and its ability to solve clinically relevant problems, along with its limitations and biases.

Details

Original languageEnglish
Pages (from-to)1183-1193
Number of pages11
JournalGut
Volume70
Issue number6
Publication statusPublished - 1 Jun 2021
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 33214163

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • cancer, computerised image analysis, histopathology